Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 8-K Event Executive or director change · Other events
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 4 Open-market sale 10% owner sold 1,523,000 shares at $18.30 ($27,870,900)
  10. 4 Open-market sale President & CEO sold 336,783 shares at an average $20.78 ($7,000,019)
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 4 Grant or award EVP, Chief Financial Officer acquired 5,000 shares (grant or award)
  13. 8-K Event Material agreement · Other events
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Open-market sale 10% owner sold 1,048,846 shares
  19. 8-K Event Executive or director change
  20. 8-K Event Executive or director change

Page 30 of 37 · 725 filings